• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

anticoagulant

Biotech

BMS, J&J's secondary stroke med doesn't stick the landing

Bristol Myers Squibbs' anticoagulant milvexian failed its phase 2 trial but accrued enough encouraging data for the company to prep phase 3 plans.
Max Bayer Aug 28, 2022 3:36am

Racing Bayer, Merck gets FDA fast-track tag for anticoagulant

Aug 23, 2022 8:40am

Bayer-Ionis' anti-thrombotic med doesn't increase bleeding

Jul 28, 2022 10:51am

Amag merges with Perosphere, adding NOAC antidote

Dec 13, 2018 9:55am

Boston Sci to distribute Veniti’s venous stent

Sep 11, 2017 11:31am

Roche debuts iOS app for blood coagulation test device

Sep 26, 2016 11:18am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy